Intel is gaining momentum as the Trump Administration considers a stake in the company, reflecting a government intervention in critical industries. Intel remains committed to supporting efforts to enhance U.S. technology leadership. Meanwhile, Apple has experienced its best week in years following a buy rating from BTIG and a price target of $198. This comes after the reintroduction of the Blood Oxygen feature in certain Apple Watch models, which had been previously disabled due to regulatory rulings. Apple is also set to release several new AI-powered devices.
Intel is gaining momentum following a Bloomberg report that the Trump Administration is in talks to have the U.S. take a stake in the stock. Such a move would mark another intervention by U.S. President Donald Trump in industries seen as vital to national security. Intel declined to comment on the report but said it was deeply committed to supporting Trump's efforts to strengthen U.S. technology and manufacturing leadership.
Analysts at BTIG have reiterated a buy rating on Apple stock with a $198 price target after Apple announced it would reintroduce its Blood Oxygen feature for certain Apple Watch models. The original Blood Oxygen feature was disabled following an International Trade Commission ruling. In January 2024, U.S. Customs and Border Protection permitted Apple to sell its Apple Watch Series 9 and Ultra 2 with a software workaround that excluded the pulse oximeter function.
Apple is also releasing other new and updated AI-powered devices, including robots, a smart speaker with display and security cameras, and an updated 'lifelike' Siri capable of communicating.
Collection
[
|
...
]